卢玉菡, 于晓玲. 微波消融联合人工辅助技术治疗近肝门处肝癌的有效性和安全性[J]. 解放军医学院学报, 2018, 39(6): 502-506. DOI: 10.3969/j.issn.2095-5227.2018.06.012
引用本文: 卢玉菡, 于晓玲. 微波消融联合人工辅助技术治疗近肝门处肝癌的有效性和安全性[J]. 解放军医学院学报, 2018, 39(6): 502-506. DOI: 10.3969/j.issn.2095-5227.2018.06.012
LU Yuhan, YU Xiaoling. Effectiveness and safety of microwave ablation combined with artificial assisted technique in treatment of hepatocellular carcinoma adjacent to hepatic hilum[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2018, 39(6): 502-506. DOI: 10.3969/j.issn.2095-5227.2018.06.012
Citation: LU Yuhan, YU Xiaoling. Effectiveness and safety of microwave ablation combined with artificial assisted technique in treatment of hepatocellular carcinoma adjacent to hepatic hilum[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2018, 39(6): 502-506. DOI: 10.3969/j.issn.2095-5227.2018.06.012

微波消融联合人工辅助技术治疗近肝门处肝癌的有效性和安全性

Effectiveness and safety of microwave ablation combined with artificial assisted technique in treatment of hepatocellular carcinoma adjacent to hepatic hilum

  • 摘要: 目的 探讨近肝门处原发性肝细胞癌(hepatocellular carcinoma,HCC)超声引导下微波消融治疗的有效性和安全性。 方法 选取2015年5月-2017年5月在本院介入超声科接受治疗的HCC患者140例(157个结节),分为两组。对照组70例(80个结节)采用微波消融配合人工腹水技术进行治疗,观察组70例(77个结节)在对照组治疗的基础上联合无水乙醇治疗。两组患者的一般资料均无统计学差异(P均> 0.05)。观察并记录两组患者的总体技术成功率、完全消融率、术后并发症发生情况以及术后3个月、6个月、12个月的肿瘤局部进展率。 结果 观察组总体技术成功率为97.14%,完全消融率为96.10%;消融主要并发症为局部疼痛、发热及恶心或呕吐;消融术后第3、6、12个月的肿瘤局部进展率分别为1.30%、2.60%、6.50%。对照组患者的总体技术成功率为95.71%,完全消融率为90%;术后第3、6和12个月的肿瘤局部进展率分别为2.5%、8.75%、13.75%;术后并发症主要有局部疼痛、发热及恶心或呕吐等。两组患者总体消融率无统计差异(P> 0.05),观察组完全消融率要高于对照组(P=0.025),3个月时肿瘤局部进展率无统计学差异(P> 0.05),6个月、12个月时肿瘤局部进展率对照组要高于观察组(P=0.04,P=0.033)。 结论 对近肝门处肝癌患者进行局部微波消融治疗是安全有效的,在消融过程中使用人工腹水技术的同时注射无水乙醇进行消融治疗,可有效提高患者的完全消融率,并降低患者肿瘤局部进展率,消融效果更好。

     

    Abstract: Objective To investigate the effectiveness and safety of ultrasound guided microwave ablation (MVA) in the treatment of hepatocellular carcinoma (HCC) adjacent to hepatic hilum of the liver. Methods A total of 140 HCC patients (157 nodules) who were treated in the ultrasound department of Chinese PLA General Hospital from May 2015 to May 2017 were enrolled. They were randomly divided into observation group and control group. In the control group, 70 patients (80 nodules) were treated by MVA combined with artificial ascites, while another 70 patients (77 nodules) in the observation group were treated with ethanol injection assisted by artificial ascites. There was no statistical difference in the general data between the two groups (P> 0.05). The overall technical success rate, complete ablation rate, postoperative complications, and local progression rate at 3 months, 6 months and 12 months after operation were observed in two groups. Results In the observation group, the overall technical success rate was 97.14%, the complete ablation rate was 96.10%, the local tumor progression rate of 3, 6 and 12 months was 1.30%, 2.60%, 6.50%respectively and the main postoperative complications were local pain, fever and nausea or vomiting. In the control group, the overall technical success rate was 95.71%, the complete ablation rate was 90%, the local tumor progression rate of 3, 6 and 12 months was 2.5%, 8.75%, 13.75%, respectively, and the postoperative complications included local pain, fever and nausea or vomiting. There was no significant difference in total ablation rate and local progression rate at 3 months between the two groups (P> 0.05), while the complete ablation rate and the local progression rate at 6 and 12 months in the observation group was higher than that of the control group (P=0.025, P=0.04, P=0.033, respectively). Conclusion Local microwave ablation is safe and effective for patients with hepatocellular carcinoma adjacent to hepatic hilum. During the ablation process, the assistive technology of artificial ascites plus ethanol injection for treatment can effectively improve the complete ablation rate, and reduce the rate of local tumor progression.

     

/

返回文章
返回